Pacira BioSciences (PCRX) Research & Development (2010 - 2026)

Pacira BioSciences' Research & Development history runs 17 years deep, the most recent figure standing at $28.1 million for Q1 2026.

• In Q1 2026, Research & Development rose 10.77% year-over-year to $28.1 million; the TTM figure through Mar 2026 stood at $119.7 million (up 34.97% YoY), while the FY2025 annual figure was $117.3 million, up 43.81% from the prior year.
• Research & Development was $28.1 million for Q1 2026 at Pacira BioSciences, down from $37.5 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $37.5 million in Q4 2025 to a low of $17.1 million in Q1 2023.
• Historically, Research & Development has averaged $22.8 million across 5 years, with a median of $20.8 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Research & Development jumped 109.04% in 2022, then retreated 28.38% in 2023.
• A 5-year view of Research & Development shows it stood at $17.5 million in 2022, then climbed by 11.19% to $19.5 million in 2023, then increased by 22.78% to $23.9 million in 2024, then surged by 56.73% to $37.5 million in 2025, then dropped by 25.05% to $28.1 million in 2026.
• The last three Research & Development figures came in at $28.1 million (Q1 2026), $37.5 million (Q4 2025), and $26.0 million (Q3 2025), per Business Quant data.